Search This Blog

Tuesday, August 6, 2019

Pacific Biosciences of California EPS beats by $0.01, beats on revenue

Pacific Biosciences of California (NASDAQ:PACB): Q2 GAAP EPS of -$0.16 beats by $0.01.
Revenue of $24.62M (+14.1% Y/Y) beats by $3.83M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)